Genetic Factors in Antidepressant Side Effects Unveiled by Biobank Data
A groundbreaking study using biobank data reveals how genetic variations influence the severity of side effects from antidepressants, paving the way for personalized mental health treatments.
Recent research conducted by scientists at the University of Tartu's Institute of Genomics has shed light on why some individuals experience more pronounced side effects when using antidepressants. By analyzing data from over 13,000 gene donors stored in the Estonian Biobank, researchers examined 25 common side effects across 16 popular antidepressants, including symptoms like nausea, weight fluctuations, sleep disturbances, headaches, and heart palpitations.
The study focused significantly on the CYP2C19 gene, which plays a crucial role in how the body metabolizes certain medications. Variations in this gene, especially the presence of a deletion mutation found in over 3% of Estonians—a genetic trait not previously documented in other populations—were linked to an increased likelihood of side effects. Slow metabolizers, who process drugs more slowly due to their genetic makeup, were nearly 50% more likely to experience adverse effects compared to those with typical metabolic rates, whereas ultra-rapid metabolizers exhibited a lower risk.
These findings emphasize the importance of personalized medicine, suggesting that genetic testing could guide dosage adjustments or alternative therapies to minimize side effects. For example, patients can check their CYP2C19 activity through the Minu Geenivaramu portal. Incorporating genetic variants like the CYP2C19 deletion into pharmacogenetic testing can enhance treatment safety, especially in Estonia.
Furthermore, the research linked genetic predispositions for psychiatric conditions such as schizophrenia and depression, as well as higher BMI, with increased side effect profiles, including weight gain and headaches. Using data mining and natural language processing on clinical records and questionnaires, scientists demonstrated the significant influence of genetics on individual responses to antidepressants.
Overall, this innovative study highlights the potential of using genetic information to tailor antidepressant therapy, leading to more effective and safer mental health treatments while reducing the risk of therapy discontinuation due to adverse effects. The results underscore the importance of integrating pharmacogenetics into clinical practice to optimize patient outcomes.
Source: https://medicalxpress.com/news/2025-07-biobank-individuals-side-effects-antidepressants.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Tool Aims to Uncover Motivations Behind Youth Loot Box Purchases in Video Games
A new assessment tool investigates why young gamers buy loot boxes, helping identify early signs of gaming-related risks and potential harms, with implications for policy and prevention strategies.
Understanding Cannabis Use Disorder: Recognizing the Signs and Risks
Cannabis use disorder affects a significant number of users, with symptoms including dependence, tolerance, and withdrawal. Recognizing the risks can help prevent problematic consumption and support responsible use.
Introducing Joy as a Key Element in Enhancing Adult Patient Experience
Discover how incorporating joy and emotional support into adult healthcare can improve patient satisfaction, reduce recovery times, and foster a more compassionate healing environment inspired by pediatric practices.
Using Mindfulness Techniques to Help Expectant Parents Manage Stress During Parenthood
Research shows that mindfulness-based childbirth and parenting classes can significantly reduce stress for expectant parents, especially those with higher anxiety, by fostering emotional resilience and stronger family support.